Sedman, T., Heinla, K., Vasar, E
The most common adverse reactions for Wegovy (incidence 5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
That said, we can draw some conclusions about PT-141s safety from the relatively little research available to us
Semaglutide's once-weekly injection schedule became the standard in clinical practice after the SUSTAIN trials demonstrated consistent weight loss and metabolic improvements on this regimen
Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study